Anthropic launches Claude Science for pharma researchers

Anthropic, the AI lab that talks a good game about responsibility, has rolled out Claude Science, a beta workbench for drug discovery researchers. The product promises to corral *dozens of databases and analysis tools* into one cozy environment — because the real bottleneck in curing disease has always been having too many browser tabs open. The move is aimed squarely at pharma researchers, a group already drowning in data and platform fatigue. One imagines the collective sigh from R&D departments as they add Yet Another AI Tool to their stack, right after they finish training on the previous three.

The timing is beautifully ironic: the pharmaceutical industry is grappling with its worst productivity crisis in decades, with R&D costs soaring and success rates flatlining. Enter Anthropic, offering a Claude-infused lifeline. Never mind that earlier AI tools for drug discovery have a habit of generating chemically plausible but synthetically impossible molecules — this time it's different because Anthropic has a constitution and therefore, presumably, moral authority over the periodic table. The *dozens of databases* may well include all the necessary data, but the challenge remains turning that data into actual medicines, a step that continues to mystify the best of us.

So here we are: another shiny AI product promising to revolutionise pharma, delivered with the gravitas of a company that positions itself as the ethical conscience of the field. The beta tag is a nice touch, suggesting Anthropic is at least aware that the thing could go sideways. In the meantime, researchers can look forward to a new learning curve, new jargon, and the same old failure rates. But the press release is out, the stock bump is real, and Claude Science is here to save us — or at least to provide a very expensive interface for data. Cheers to that.